EP2134322
INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.3.2008EP published:
20.2.2019EP application number:
08732162.6
EPO information:
European Patent Register
Max expiry date:
12.3.2028
Title:
INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER
Timeline
Today
13.3.2008EP application
20.2.2019EP Publication
Owner
Name:
Spectrum Pharmaceuticals, Inc.Address:
157 Technology Drive, 92618, Irvine, CA, US
Inventor
Name:
LENAZ, LuigiAddress:
Newton, PA, US
Name:
CHAWLA, ShantaAddress:
Irvine, CA, US
Name:
BEER, MarioAddress:
San Clemente, CA, US
Priority
Number:
894610 PDate:
13.3.2007Country:
US
Classification
Categories:
A61K 9/19, A61K 31/404, A61P 35/00